Terms: = Ovarian cancer AND CARS, P49589, 833, ENSG00000110619 AND Diagnosis
8 results:
1. SJI 2020 special issue: A catalogue of ovarian cancer targets for CAR therapy.
Benard E; Casey NP; Inderberg EM; Wälchli S
Scand J Immunol; 2020 Oct; 92(4):e12917. PubMed ID: 32557659
[TBL] [Abstract] [Full Text] [Related]
2. Increased risk for depression persists for years among women treated for gynecological cancers - a register-based cohort study with up to 19 years of follow-up.
Horsboel TA; Kjaer SK; Johansen C; Suppli NP; Ammitzbøll G; Frøding LP; Lajer H; Dalton SO
Gynecol Oncol; 2019 Jun; 153(3):625-632. PubMed ID: 30975472
[TBL] [Abstract] [Full Text] [Related]
3. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic value of medical thoracoscopy in malignant pleural effusion.
Wu YB; Xu LL; Wang XJ; Wang Z; Zhang J; Tong ZH; Shi HZ
BMC Pulm Med; 2017 Aug; 17(1):109. PubMed ID: 28778184
[TBL] [Abstract] [Full Text] [Related]
5. Diagnostic Accuracy of Serum Kallikrein-Related Peptidases for ovarian cancer: A Systematic Review and Meta-Analysis.
Lan Z; Wang F; Yu X; Zeng X; Xi M
Int J Gynecol Cancer; 2016 Oct; 26(8):1366-74. PubMed ID: 27465901
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010).
Solheim O; Gershenson DM; Tropé CG; Rokkones E; Sun CC; Weedon-Fekjaer H; Fosså SD
Eur J Cancer; 2014 Jul; 50(11):1942-50. PubMed ID: 24857045
[TBL] [Abstract] [Full Text] [Related]
7. Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the ovarian cancer Association Consortium.
Amankwah EK; Wang Q; Schildkraut JM; Tsai YY; Ramus SJ; Fridley BL; Beesley J; Johnatty SE; Webb PM; Chenevix-Trench G; ; Dale LC; Lambrechts D; Amant F; Despierre E; Vergote I; Gayther SA; Gentry-Maharaj A; Menon U; Chang-Claude J; Wang-Gohrke S; Anton-Culver H; Ziogas A; Dörk T; Dürst M; Antonenkova N; Bogdanova N; Brown R; Flanagan JM; Kaye SB; Paul J; Bützow R; Nevanlinna H; Campbell I; Eccles DM; Karlan BY; Gross J; Walsh C; Pharoah PD; Song H; Krüger Kjær S; Høgdall E; Høgdall C; Lundvall L; Nedergaard L; Kiemeney LA; Massuger LF; van Altena AM; Vermeulen SH; Le ND; Brooks-Wilson A; Cook LS; Phelan CM; Cunningham JM; Vachon CM; Vierkant RA; Iversen ES; Berchuck A; Goode EL; Sellers TA; Kelemen LE
PLoS One; 2011; 6(5):e19642. PubMed ID: 21637745
[TBL] [Abstract] [Full Text] [Related]
8. Characterization of serum biomarkers for detection of early stage ovarian cancer.
Kozak KR; Su F; Whitelegge JP; Faull K; Reddy S; Farias-Eisner R
Proteomics; 2005 Nov; 5(17):4589-96. PubMed ID: 16237736
[TBL] [Abstract] [Full Text] [Related]
